Preventing postoperative nausea and vomiting: Effect of Neurokinin-1 receptor antagonist(Fosaprepitant)

Trial Profile

Preventing postoperative nausea and vomiting: Effect of Neurokinin-1 receptor antagonist(Fosaprepitant)

Completed
Phase of Trial: Phase IV

Latest Information Update: 30 Jul 2015

At a glance

  • Drugs Fosaprepitant (Primary)
  • Indications Postoperative nausea and vomiting
  • Focus Therapeutic Use
  • Most Recent Events

    • 17 Oct 2013 Planned number of patients changed from 100 to 200 as reported by University Hospital Medical Information Network - Japan.
    • 18 May 2012 Status changed from not yet recruiting to recruiting as reported by University Hospital Medical Information Network - Japan.
    • 02 Apr 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top